(S)-SLV 319 structure
|
Common Name | (S)-SLV 319 | ||
---|---|---|---|---|
CAS Number | 464213-10-3 | Molecular Weight | 487.401 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 623.2±65.0 °C at 760 mmHg | |
Molecular Formula | C23H20Cl2N4O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 330.7±34.3 °C |
Use of (S)-SLV 319Ibipinabant, also known as BMS-646256, JD-5001 and SLV-319, is a potent and highly selective CB1 antagonist. It has potent anorectic effects in animals, and was researched for the treatment of obesity, although CB1 antagonists as a class have now fallen out of favour as potential anorectics following the problems seen with rimonabant, and so ibipinabant is now only used for laboratory research, especially structure-activity relationship studies into novel CB1 antagonists. |
Name | (4S)-5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide |
---|---|
Synonym | More Synonyms |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 623.2±65.0 °C at 760 mmHg |
Molecular Formula | C23H20Cl2N4O2S |
Molecular Weight | 487.401 |
Flash Point | 330.7±34.3 °C |
Exact Mass | 486.068390 |
PSA | 82.51000 |
LogP | 4.67 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.663 |
1H-Pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-N'-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N-methyl-4-phenyl-, (4S)- |
UNII-O5CSC6WH1T |
(4S)-3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-N'-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide |
ibipinabant |
1H-pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4-phenyl-, (4S)- |